Clinical Trial Update: FANTOM Post Market Clinical Trial [NA]

View source ↗

Summary

This is a post-market clinical trial update showing that the FANTOM device from REVA Medical is actively recruiting for Coronary Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• FANTOM

Snippet

Sponsor: REVA Medical, Inc. | Conditions: Coronary Artery Disease | NA | Status: RECRUITING